ALUNG Apr. 20/4
نویسندگان
چکیده
Sato, Koichi, David M. Rodman, and Ivan F. McMurtry. Hypoxia inhibits increased ETB receptor-mediated NO synthesis in hypertensive rat lungs. Am. J. Physiol. 276 (Lung Cell. Mol. Physiol. 20): L511–L581, 1999.—Although hypertensive lungs of chronically hypoxic rats express increased levels of nitric oxide (NO) synthases (NOSs) and produce increased amounts of NO-containing compounds (NOx) during normoxic ventilation, the level of NO production during hypoxic exposure is unclear. Because hypoxia inhibits NO synthesis in normotensive lungs, we investigated whether hypoxic ventilation inhibited NO synthesis in isolated hypertensive lungs and chronically hypoxic rats. Measurement of perfusate NOx concentration in hypertensive lungs from male rats exposed to 4 wk of hypobaric hypoxia showed that basal NOx production was reduced during hypoxic (0% O2) vs. normoxic (21% O2) ventilation. Similarly, plasma NOx concentration was lower in chronically hypoxic rats breathing 10% O2 than in those breathing 21% O2. Hypoxic inhibition of lung NOx production was not prevented by supplementary L-arginine or tetrahydrobiopterin and was not mimicked by inhibition of Ca21 influx. However, it was mimicked by inhibition of constitutive NOS with NG-monomethyl-Larginine and chelation of intracellular Ca21. The endothelin type B-receptor antagonist BQ-788 prevented the increases in NOx production associated with normoxic ventilation in both isolated hypertensive lungs and intact chronically hypoxic rats. These results suggest that a reduced supply of the cosubstrate molecular O2 to NOS counteracts an endothelin type B receptor-mediated stimulation of NO synthesis in hypertensive rat lungs. Thus, despite increased NOS protein in the lungs and pulmonary arteries of chronically hypoxic rats, direct hypoxic inhibition of NO production may contribute to the development of pulmonary hypertension.
منابع مشابه
ALUNG Apr. 20/4
NADES PALANIYAR,1 ROSS A. RIDSDALE,1 STEPHEN A. HEARN,2 YEW MENG HENG,3 F. PETER OTTENSMEYER,3 FRED POSSMAYER,4 AND GEORGE HARAUZ1 1Department of Molecular Biology and Genetics, University of Guelph, Guelph N1G 2W1; 2Department of Pathology, St. Joseph’s Health Center, London N6A 4L6; 3Division of Molecular and Structural Biology, Ontario Cancer Institute, and Department of Medical Biophysics, ...
متن کاملALUNG Apr. 20/4
Reed, Jacquelyn A., Machiko Ikegami, Eli R. Cianciolo, Wei Lu, Patricia S. Cho, William Hull, Alan H. Jobe, and JeffreyA. Whitsett. Aerosolized GM-CSF ameliorates pulmonary alveolar proteinosis in GM-CSF-deficient mice. Am. J. Physiol. 276 (Lung Cell. Mol. Physiol. 20): L556–L563, 1999.—Surfactant proteins and phospholipids accumulate in the alveolar spaces and lung tissues of mice deficient in...
متن کاملSe p 20 15 A Note On Spectral Clustering ∗ Pavel Kolev Kurt
Let G = (V,E) be an undirected graph, λk the kth smallest eigenvalue of the normalized Laplacian matrix of G, and ρ(k) the smallest value of the maximal conductance over all k-way partitions S1, . . . , Sk of V . Peng et al. [4] gave the first rigorous analysis of k-clustering algorithms that use spectral embedding and k-means clustering algorithms to partition the vertices of a graph G into k ...
متن کاملALUNG October 21/4
TIMOTHY D. LE CRAS,1 DUG-HA KIM,2 SARAH GEBB,3 NEIL E. MARKHAM,1 JOHN M. SHANNON,3 RUBIN M. TUDER,4 AND STEVEN H. ABMAN1 1Pediatric Heart Lung Center, Department of Pediatrics, and 4Department of Pathology, University of Colorado School of Medicine and The Children’s Hospital, Denver 80262; 3National Jewish Hospital, Denver, Colorado 80206; and 2Department of Pediatrics, Hallym University, 150-...
متن کاملOlanzapine versus aprepitant for the prevention of chemotherapy-induced nausea and vomiting: a randomized phase III trial.
BACKGROUND The purpose of the study was to compare the effectiveness of olanzapine (OLN) and aprepitant (APR) for the prevention of chemotherapy-induced nausea and vomiting (CINV) in patients receiving highly emetogenic chemotherapy. METHODS A phase III trial was performed in chemotherapy-naive patients receiving cisplatin ≥ 70 mg/m(2) or cyclophosphamide ≥ 500 mg/m(2) and doxorubicin ≥ 50 mg...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
دوره شماره
صفحات -
تاریخ انتشار 1999